Agilent Technologiesvs.Illumina
A vs ILMN · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Agilent Technologies is about 1.3× larger than Illumina by market cap; Agilent Technologies trades at the lower P/E (26.8 vs 33.7); year to date, Illumina leads (+45.0% vs −1.3%).
Side by side
| A | ILMN | |
|---|---|---|
| Market cap | $37.9B | $28.8B |
| Price | $134.29 | $190.20 |
| Today | +0.5% | −1.8% |
| Return YTD | −1.3% | +45.0% |
| Return 1Y | +8.2% | +90.1% |
| P/E | 26.8 | 33.7 |
| P/S | 5.2 | 6.6 |
| P/B | 5.3 | 10.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Agilent TechnologiesA
American manufacturer of analytical instruments and laboratory solutions for life science, diagnostics and chemical analysis.
Full A profile →IlluminaILMN
American leader in DNA sequencing — instruments and consumables used in research and clinical genomics.
Full ILMN profile →More comparisons in Life science tools
See where A and ILMN sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →